{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:55:37Z","timestamp":1790610937178,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572893"],"award-info":[{"award-number":["81572893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972358"],"award-info":[{"award-number":["81972358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2017733"],"award-info":[{"award-number":["BE2017733"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20180036"],"award-info":[{"award-number":["BK20180036"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["18KJB180014"],"award-info":[{"award-number":["18KJB180014"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.biopha.2020.109966","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T01:52:07Z","timestamp":1580435527000},"page":"109966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Interferon-\u03b12b enhances survival and modulates transcriptional profiles and the immune response in melanoma patients treated with dendritic cell vaccines"],"prefix":"10.1016","volume":"125","author":[{"given":"Liuxue","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sali","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.109966_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3264217","article-title":"Advances in immunotherapy for melanoma: a comprehensive review","volume":"2017","author":"Rodriguez-Cerdeira","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2020.109966_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8097398","article-title":"Novel immunotherapeutic approaches for neuroblastoma and malignant melanoma","volume":"2018","author":"Morandi","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.109966_bib0015","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41467-017-00784-1","article-title":"Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.109966_bib0020","article-title":"Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression","author":"Saleh","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"6230","key":"10.1016\/j.biopha.2020.109966_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.biopha.2020.109966_bib0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.109966_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"Pt 23","key":"10.1016\/j.biopha.2020.109966_bib0040","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J. Cell. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2020.109966_bib0045","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and Cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2020.109966_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01764","article-title":"Tolerance through education: how tolerogenic dendritic cells shape immunity","volume":"8","author":"Domogalla","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2020.109966_bib0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fimmu.2013.00417","article-title":"Clinical implications of Co-inhibitory molecule expression in the tumor microenvironment for DC vaccination: a game of stop and go","volume":"4","author":"Vasaturo","year":"2013","journal-title":"Front. Immunol."},{"issue":"7161","key":"10.1016\/j.biopha.2020.109966_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2020.109966_bib0065","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1057673","article-title":"Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination","volume":"5","author":"Bol","year":"2016","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.biopha.2020.109966_bib0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/CMR.0000000000000441","article-title":"Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma","volume":"28","author":"Geskin","year":"2018","journal-title":"Melanoma Res."},{"issue":"11","key":"10.1016\/j.biopha.2020.109966_bib0075","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity","volume":"4","author":"Bottcher","year":"2018","journal-title":"Trends Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2020.109966_bib0080","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","article-title":"Dendritic cell-based immunotherapy: state of the art and beyond","volume":"22","author":"Bol","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.biopha.2020.109966_bib0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.21037\/atm.2017.06.13","article-title":"Dendritic cell therapy in melanoma","volume":"5","author":"Alvarez-Dominguez","year":"2017","journal-title":"Ann. Transl. Med."},{"issue":"7","key":"10.1016\/j.biopha.2020.109966_bib0090","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1191732","article-title":"Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients","volume":"5","author":"Boudewijns","year":"2016","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.biopha.2020.109966_bib0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2014.11.008","article-title":"The use of interferon in melanoma patients: a systematic review","volume":"26","author":"Di Trolio","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.biopha.2020.109966_bib0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00281-011-0247-y","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"33","author":"Krauze","year":"2011","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.biopha.2020.109966_bib0105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/CJI.0b013e31821dcb31","article-title":"Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma","volume":"34","author":"Wilgenhof","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.biopha.2020.109966_bib0110","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0552-x","article-title":"Multiple antigen-engineered DC vaccines with or without IFN alpha to promote antitumor immunity in melanoma","volume":"7","author":"Butterfield","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2020.109966_bib0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00262-017-2072-1","article-title":"Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy","volume":"67","author":"Balatoni","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.biopha.2020.109966_bib0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2020.109966_bib0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fimmu.2019.00014","article-title":"CD56(dim) CD16(-) natural killer cell profiling in melanoma patients receiving a Cancer vaccine and interferon-alpha","volume":"10","author":"Vujanovic","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2020.109966_bib0130","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2020.109966_bib0135","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"10","key":"10.1016\/j.biopha.2020.109966_bib0140","article-title":"Correction: MicroRNA-17 and the prognosis of human carcinomas: a systematic review and meta-analysis","volume":"8","author":"Huang","year":"2018","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.biopha.2020.109966_bib0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.160.3.1139","article-title":"Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha","volume":"160","author":"Tuting","year":"1998","journal-title":"J. Immunol."},{"issue":"35 Pt B","key":"10.1016\/j.biopha.2020.109966_bib0150","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1016\/j.vaccine.2017.07.032","article-title":"Targeting interferon-alpha to dendritic cells enhances a CD8(+) T cell response to a human CD40-targeted cancer vaccine","volume":"35","author":"Graham","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.biopha.2020.109966_bib0155","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356964","article-title":"Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy","volume":"6","author":"Montico","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.biopha.2020.109966_bib0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/CMR.0000000000000254","article-title":"Treatment patterns of adjuvant interferon-alpha2b for high-risk melanoma: a retrospective study of the Grupo Espanol Multidisciplinar de Melanoma - Prima study","volume":"26","author":"Espinosa","year":"2016","journal-title":"Melanoma Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.109966_bib0165","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2010.10.007","article-title":"Designing vaccines based on biology of human dendritic cell subsets","volume":"33","author":"Palucka","year":"2010","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.biopha.2020.109966_bib0170","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s13058-014-0488-5","article-title":"Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer","volume":"16","author":"Garcia-Martinez","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biopha.2020.109966_bib0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02169","article-title":"Determination of t follicular helper cell fate by dendritic cells","volume":"9","author":"Krishnaswamy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2020.109966_bib0180","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.biopha.2016.10.083","article-title":"Development of T follicular helper cells and their role in disease and immune system","volume":"84","author":"Eivazi","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.biopha.2020.109966_bib0185","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI67428","article-title":"CD4(+) follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.biopha.2020.109966_bib0190","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1175800","article-title":"Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer","volume":"5","author":"Timperi","year":"2016","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.biopha.2020.109966_bib0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/imt-2016-0138","article-title":"Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy","volume":"9","author":"Moreira","year":"2017","journal-title":"ImmunotherapyUk"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:55:33Z","timestamp":1790607333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220301566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":39,"alternative-id":["S0753332220301566"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109966","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03b12b enhances survival and modulates transcriptional profiles and the immune response in melanoma patients treated with dendritic cell vaccines","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109966"}}